Chain requested a hearing before the Ohio Board of Pharmacy to explain purchase of repackaged Kroger merchandise that was transferred to two Revco units in Ohio. Revco's appearance before the Ohio pharmacy board did not pertain to drug diversion ("The Pink Sheet" April 21, p. 9). Under FDA regulations, a chain may buy a product in bulk and repackage it in smaller sizes for sale solely within its own stores. Revco told the Ohio pharmacy board it was unaware that the inventory acquired from Kroger had been repackaged.
You may also be interested in...
The UK's Optibac responds to sustainability and naturals trends with an all-in-one immunity and gut health food supplement especially designed for children.
Legal experts tell the Pink Sheet why India’s plans to abolish the Intellectual Property Appellate Board and shift its powers to courts may be problematic for stakeholders, including those pursuing infringement charges. The transition could mean a significant burden on courts both in terms of capability and capacity, and IPR cases will now conflate into all other pending commercial matters, some experts said, though others cheered the proposed change.
Tyto Care’s remote monitoring and telehealth platform has seen rising demand since the start of the pandemic and the company continues to expand. This week, it announced it raised $50m in a series D financing round. See what Dedi Gilad, CEO of Tyto Care, said about it here.